Key result
Ventricular arrhythmias are documented in up to 85% of patients with severe congestive heart failure, for whom implantable cardioverter-defibrillators are highly effective at reducing mortality.
Population
Patients with heart failure at risk of sudden cardiac death
Design
Review
Authors
Loading...
High VA prevalence in severe HF affirms ICD mortality benefit; leaves open refined risk stratification for optimal patient selection.
This review highlights the ongoing challenge of risk-stratifying heart failure patients to identify those who would most benefit from ICD implantation for the prevention of sudden cardiac death.
Rebecca Lane (2005) conducted a review in Heart failure. Implantable cardioverter-defibrillator (ICD) was evaluated. Ventricular arrhythmias are documented in up to 85% of patients with severe congestive heart failure, for whom implantable cardioverter-defibrillators are highly effective at reducing mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: